Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda

Table 5 Cost-effectiveness of TB diagnosis using MODS or Xpert in a base-case analysis for a cohort of 10,000 HIV presumptive PTB patients

Strategy	Mean cost per test ($)	incremental cost per test ($)	Cases detected	Incremental cases detected	Cost effectiveness	ICER
MODS	6.53		1920		34	More cost effective
Xpert	12.41	(5.88)	1740	180	71	Dominated

ISSN: 1472-6963